Eisai
4523.T
#2295
Rank
โ‚น785.52 B
Marketcap
โ‚น2,787
Share price
-2.25%
Change (1 day)
15.17%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น81.24. an increase over its 2024 EPS that were of โ‚น91.58.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025โ‚น102.4411.85%
2024โ‚น91.58-32.63%
2023โ‚น135.945.52%
2022โ‚น128.83-74.01%
2021โ‚น495.64-66.58%
2020โ‚น1,48398.24%
2019โ‚น748.0017.01%
2018โ‚น639.2637.78%
2017โ‚น463.98-27.62%
2016โ‚น641.0535.33%
2015โ‚น473.70-2.82%
2014โ‚น487.45-27.66%
2013โ‚น673.88-27.49%
2012โ‚น929.40-12.67%
2011โ‚น1,06488.08%
2010โ‚น565.87-11.06%
2009โ‚น636.26-390.15%
2008-โ‚น219.29-127.78%
2007โ‚น789.4711.78%
2006โ‚น706.294.38%
2005โ‚น676.687.4%
2004โ‚น630.0843.03%
2003โ‚น440.5425.09%
2002โ‚น352.1752.67%
2001โ‚น230.6769.76%
2000โ‚น135.88